Non Consignment Sales was Staar Surgical’s largest revenue line in fiscal 2026, bringing in $178.99M of $239.44M (75%).
| Sales Category Axis | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Non Consignment Sales | $301.16M | $293.57M | $178.99M | |||||||
| Consignment Sales | $21.25M | $20.33M | $60.45M | |||||||
| Total | $322.42M | $313.90M | $239.44M |
Staar Surgical brought in $239.44M from its two revenue lines in fiscal 2026, the year ended January 2, 2026. That was down 23.7% from $313.90M in fiscal 2024, the previous year with figures. Non Consignment Sales was the largest at $178.99M (74.8%), ahead of Consignment Sales at $60.45M (25.2%).
Compared with fiscal 2024, the previous year with figures, Consignment Sales grew 197.4% to $60.45M, while Non Consignment Sales fell 39.0% to $178.99M. From fiscal 2023 to 2026, combined revenue from these revenue lines fell from $322.42M to $239.44M, a compound annual decline of 9.4%. Non Consignment Sales' share of the total fell from 93.4% to 74.8%.
Geographic Distribution, Foreign was Staar Surgical’s largest region in fiscal 2026, bringing in $216.88M of $239.44M (91%).
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Geographic Distribution, Foreign | $305.19M | $294.01M | $216.88M | |||||||
| Geographic Distribution, Domestic | $17.22M | $19.90M | $22.56M | |||||||
| Total | $322.42M | $313.90M | $239.44M |
Staar Surgical brought in $239.44M from its two regions in fiscal 2026, the year ended January 2, 2026. That was down 23.7% from $313.90M in fiscal 2024, the previous year with figures. Geographic Distribution, Foreign was the largest at $216.88M (90.6%), ahead of Geographic Distribution, Domestic at $22.56M (9.4%).
Compared with fiscal 2024, the previous year with figures, Geographic Distribution, Domestic grew 13.4% to $22.56M, while Geographic Distribution, Foreign fell 26.2% to $216.88M. From fiscal 2023 to 2026, combined revenue from these regions fell from $322.42M to $239.44M, a compound annual decline of 9.4%. Geographic Distribution, Foreign's share of the total fell from 94.7% to 90.6%.
Implantable Collamer Lenses was Staar Surgical’s largest revenue line in fiscal 2017, bringing in $68.33M of $90.61M (75%).
| Products and Services | FY 2010 | FY 2011 | FY 2012 | FY 2014 | FY 2015 | FY 2016 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Implantable Collamer Lenses | $44.13M | $44.05M | $51.54M | $59.11M | $68.33M | |||
| Intraocular Lenses | $24.15M | $24.34M | $19.86M | $19.71M | $17.26M | |||
| Other Surgical Products | $3.93M | $6.60M | $5.72M | $3.62M | $5.03M | |||
| Total | $72.22M | $74.99M | $77.12M | $82.43M | $90.61M |
Staar Surgical brought in $90.61M from its three revenue lines in fiscal 2017, the year ended December 29, 2017. That was up 9.9% from $82.43M in fiscal 2016. Implantable Collamer Lenses was the largest at $68.33M (75.4%), ahead of Intraocular Lenses at $17.26M (19.0%) and Other Surgical Products at $5.03M (5.5%).
Compared with fiscal 2016, Other Surgical Products grew fastest, up 39.1% to $5.03M, while Intraocular Lenses fell the most, down 12.4% to $17.26M. From fiscal 2014 to 2017, combined revenue from these revenue lines grew from $72.22M to $90.61M, a compound annual growth rate of 7.9%. Implantable Collamer Lenses' share of the total rose from 61.1% to 75.4%.
Staar Surgical (STAA) reports its revenue by sales category axis, by geography and by products and services. In fiscal 2026, Non Consignment Sales was its largest revenue line, bringing in $178.99M (74.8% of the total), followed by Consignment Sales at $60.45M (25.2%).
Non Consignment Sales was Staar Surgical's largest revenue line in fiscal 2026, bringing in $178.99M, or 74.8% of the $239.44M total across its two revenue lines.
Geographic Distribution, Foreign was Staar Surgical's largest region in fiscal 2026, bringing in $216.88M, or 90.6% of the $239.44M total across its two regions.
Among Staar Surgical's revenue lines that make up at least 2% of revenue, Other Surgical Products grew fastest in fiscal 2017, up 39.1% from $3.62M to $5.03M.
Every figure comes from Staar Surgical's annual financial filings, as reported. Each line keeps the name Staar Surgical gives it, and years follow its fiscal calendar.
Staar Surgical's revenue by sales category axis goes back to fiscal 2016, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.